Kevin Norrett - Net Worth and Insider Trading

Kevin Norrett Net Worth

The estimated net worth of Kevin Norrett is at least $310,002 dollars as of 2024-10-06. Kevin Norrett is the COO of Codexis Inc and owns about 98,102 shares of Codexis Inc (CDXS) stock worth over $310,002. Details can be seen in Kevin Norrett's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin Norrett has not made any transactions after 2023-09-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kevin Norrett

To

Kevin Norrett Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kevin Norrett owns 2 companies in total, including Sierra Oncology Inc (SRRA) , and Codexis Inc (CDXS) .

Click here to see the complete history of Kevin Norrett’s form 4 insider trades.

Insider Ownership Summary of Kevin Norrett

Ticker Comapny Transaction Date Type of Owner
SRRA Sierra Oncology Inc 2020-08-10 Chief Business Officer
CDXS Codexis Inc 2023-09-11 Chief Operating Officer

Kevin Norrett Latest Holdings Summary

Kevin Norrett currently owns a total of 1 stock. Kevin Norrett owns 98,102 shares of Codexis Inc (CDXS) as of September 11, 2023, with a value of $310,002.

Latest Holdings of Kevin Norrett

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CDXS Codexis Inc 2023-09-11 98,102 3.16 310,002

Holding Weightings of Kevin Norrett


Kevin Norrett Form 4 Trading Tracker

According to the SEC Form 4 filings, Kevin Norrett has made a total of 2 transactions in Codexis Inc (CDXS) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Codexis Inc is the acquisition of 9,000 shares on September 11, 2023, which cost Kevin Norrett around $15,480.

Insider Trading History of Kevin Norrett

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kevin Norrett Trading Performance

GuruFocus tracks the stock performance after each of Kevin Norrett's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin Norrett is 18.75%. GuruFocus also compares Kevin Norrett's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin Norrett within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kevin Norrett's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kevin Norrett

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 17.05 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 19.51 LIMIT LIMIT LIMIT LIMIT LIMIT

Kevin Norrett Ownership Network

Ownership Network List of Kevin Norrett

No Data

Ownership Network Relation of Kevin Norrett

Insider Network Chart

Kevin Norrett Owned Company Details

What does Sierra Oncology Inc do?

Who are the key executives at Sierra Oncology Inc?

Kevin Norrett is the Chief Business Officer of Sierra Oncology Inc. Other key executives at Sierra Oncology Inc include director & 10 percent owner Vivo Opportunity Fund Holdings, L.p. , Chief Reg & Tech Ops Officer William D. Turner , and General Counsel Mary Christina Thomson .

Sierra Oncology Inc (SRRA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sierra Oncology Inc (SRRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sierra Oncology Inc (SRRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sierra Oncology Inc (SRRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sierra Oncology Inc Insider Transactions

No Available Data

Kevin Norrett Mailing Address

Above is the net worth, insider trading, and ownership report for Kevin Norrett. You might contact Kevin Norrett via mailing address: C/o Sierra Oncology, Inc., 1820 Gateway Drive, Suite 110, San Mateo Ca 94404.

Discussions on Kevin Norrett

No discussions yet.